A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

More than three-quarters of older adults with dementia may be unaware of their diagnosis, a University of Michigan study ...

A new study reveals that over 75% of older adults with dementia may not know they have the disease, with awareness rates even ...

The new estimate is based on a new study that found a higher lifetime risk than previously thought: After age 55, people have ...

Researchers at the University of Michigan found that 80 percent of participants with suspected dementia had not been told they had the disease or showed early signs.

Researchers at the University of Michigan found that 80 percent of participants with suspected dementia had not been told ...

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...

"Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades, with ...

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...